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Background: Collection of nasal secretions is important for the evaluation of upper airways inflammation in many nasal
disorders.
Objective: To study the validity and reproducibility of nasal secretion cellularity induced by nebulization of hypertonic
solution in patients with allergic rhinitis (AR), patients with nonallergic rhinitis with eosinophilia syndrome (NARES), and
control subjects.
Methods: Sixty-eight individuals (29 with AR [mean  SD age, 33.3  16.9 years], 23 with NARES [mean  SD age,
46.4  16.6 years], and 16 controls [mean  SD age, 42.1  15.1 years]) underwent ultrasonic nebulization of hypertonic
(4.5%) saline solution on 2 different occasions to study the validity and reproducibility of total and differential cell counts
of nasal secretions.
Results: The mean  SD percentage of eosinophils was significantly higher in samples from patients with AR (20.8% 
23.1%) and NARES (18.7%  22.8%) than in samples from controls (0.6%  0.6%; P  .001 for both). There was a significant
correlation between 2 samples of nasal secretions obtained on 2 different occasions for percentages of macrophages, neutrophils,
eosinophils, and epithelial cells.
Conclusions: The analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution can distinguish
patients with AR and NARES from controls. The reproducibility of this technique is good for macrophages, neutrophils,
eosinophils, and epithelial cells. This method could be used to detect nasal airway inflammation in clinical settings.
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INTRODUCTION
Collection of nasal secretions is important for the evaluation
of upper airways inflammation in many nasal disorders. Ev-
idence has been provided that inflammatory cells are present
not only in the airways of patients with asthma but also in the
airways of patients with seasonal allergic rhinitis (AR).1
Physicians and researchers are often faced with the prob-
lem of collecting adequate samples of nasal secretions. Var-
ious techniques have been used to obtain specimens from
nasal mucosa and to study inflammation in the nasal cavity.2
The most commonly used techniques include nasal lavage,
nasal biopsy, nasal brush, nasal scraping, nasal mucosa col-
lection, application of a microsuction, and direct aspiration of
secretion.3–6 Each method has several disadvantages, includ-
ing being invasive procedures and the unsuitability of some
samples for analysis. Furthermore, direct comparison of the
validity and reproducibility of these methods in the same
group of patients has never been performed.
Recently, a new noninvasive method for obtaining nasal
secretion samples based on nebulization of hypertonic solu-
tion was described.7 Samples obtained using this method are
suitable for morphologic analysis. To our knowledge, no
studies have analyzed and validated the results of examina-
tion of nasal secretions obtained by means of nebulization of
hypertonic solution from patients with AR, patients with
nonallergic rhinitis with eosinophilia syndrome (NARES),
and control subjects. Thus, the aim of the present study is to
assess the validity (ability to distinguish disease vs normality)
of the method based on nebulization of hypertonic solution
for the analysis of nasal secretions obtained from patients with
AR, patients with NARES, and controls by comparing total and
differential cell counts. In addition, the reproducibility of
the method was examined by comparing measurements in
2 samples of nasal secretions obtained on 2 different
occasions in a group of patients with AR, patients with
NARES, and controls.
* Department of Internal Medicine, Immunology, and Infectious Diseases,
University of Bari Medical School, Policlinico, Bari, Italy.
† Fondazione Salvatore Maugeri, Care and Research Institute, Cassano Delle
Murge, Bari, Italy.
‡ Department of Respiratory Diseases, University of Foggia, Foggia, Italy.
§ Institute of Respiratory Diseases, University of Medicine, Bari, Italy.
 World Health Organization Collaborating Centre for TB and Lung Dis-
eases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,
Varese, Italy.
¶ Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Va-
rese, Italy.
Authors have nothing to disclose.
Received for publication February 23, 2007.
Received in revised form April 24, 2007.
Accepted for publication May 14, 2007.
232 ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY
MATERIALS AND METHODS
Patients
Sixty-eight individuals were enrolled to study the validity of
the nasal secretion method: 16 controls and 52 patients with
either AR (n  29) or NARES (n  23) (Table 1). Twenty-
nine of the 68 participants did not show up for the second
induction of nasal secretion or did not produce adequate
sample on either the first or the second occasion. Thus, the
reproducibility of the method was studied using 39 individ-
uals (17 with AR, 12 with NARES, and 10 controls). AR was
diagnosed on the basis of a positive skin test reaction to 1 or
more allergens, positive allergen specific IgE antibody test
results, and a history of seasonal symptoms.8 NARES was
defined as a clinical syndrome comprising symptoms consis-
tent with AR in which an absence of atopy has been demon-
strated by allergen skin testing, and nasal cytologic analysis
demonstrates eosinophils.9
Study Design
Each participant enrolled in the study underwent ultrasonic
nebulization of hypertonic (4.5%) saline solution on 2 differ-
ent occasions at the same hour of the day within 1 week to
study the reproducibility of total and differential cell counts
of nasal secretion. The validity of the method was evaluated
by comparing differential cell counts of nasal secretions
obtained from patients with AR, patients with NARES, and
controls. The protocol was approved by the ethics committee
of Fondazione Salvatore Maugeri, and all the participants
provided written informed consent.
Ultrasonic Nebulization of Hypertonic Saline Solution
Ultrasonic nebulization of hypertonic (4.5%) saline solution
was generated using an ultrasonic nebulizer (Orion 2; Nova,
Heyer, Germany) at maximum output power (4.4 mL/min)
for 5 minutes.7 During nebulization the participants had their
necks extended to facilitate penetration of the inhaled solu-
tion on the whole surface of the nasal mucosa, including the
posterior nasal cavity. The mean size of particles inhaled
through the nose was 2.5 to 5.0 m. After 5 minutes of
inhalation the participants were asked to press the left nostril
and to blow the right nostril forcefully into a Petri dish. The
blowing procedure was repeated for the left nostril.
Sample Processing
The secretions collected were processed.7 In brief, the secre-
tions were immediately weighted, and dithiothreitol 0.1%
reagent (Sputolysin; Calbiochem Corp, San Diego, Califor-
nia) freshly prepared was added to the secretions. The volume
of dithiothreitol was equal to 4 times the weight of the
secretions portion. The sample was placed at 37°C for 20
minutes and was vortexed every 5 minutes to ensure cell
dispersion. The sample was then filtered on sterile gauze, and
a small volume (20 L) was used to evaluate total cell counts
using a standard hemocytometer. The sample was then di-
vided into 2 aliquots: 1 was diluted to obtain a final cellular
concentration of 2  105/mL; 100 L of this sample was
cytocentrifuged at 400 rpm for 5 minutes; the slides were
stained with a Romanowski-based stain (Diff-Quik; Dade
Behring AG, Du¨dingen, Switzerland), and a differential cell
count was performed on 200 cells.
Statistical Analysis
Descriptive statistics were used to summarize clinical and
demographic characteristics of the participants. The results
are expressed as mean  SD for age, lung function values,
and cellular composition of nasal secretions. The comparison
of differential cell counts between patients with rhinitis and
controls was evaluated using t tests. The reproducibility of
measurements was examined using the Pearson correlation
coefficient. P  .05 was considered statistically significant.
RESULTS
Cellular Composition of Nasal Secretion Samples
The percentage of eosinophils was significantly higher in
samples from patients with AR (20.8%  23.1%) and
NARES (18.7%  22.8%) than in samples from controls
(0.6%  0.6%; P  .001 for both) (Table 2). Samples of
nasal secretions collected from patients with AR (1.2% 
1.4%) and NARES (1.2  1.0) were characterized by an
increased percentage of lymphocytes compared with controls
(0.0%  0.0%; P  .001 for both). The percentage of
neutrophils increased significantly in samples from patients
with NARES vs controls (78.0%  21.0% vs 65.4% 
20.7%; P  .04), whereas this increase was not significant in
patients with AR (70.8%  25.9% vs 65.4%  20.7%; P 
.22). The percentage of epithelial cells (AR vs controls: 5.9%
 12.5% vs 30.1%  19.6%; NARES vs controls: 2.0% 
3.8% vs 30.1%  19.6%; P  .001 for both) and macro-
phages (AR vs controls: 1.2%  6.7% vs 3.9%  2.8%; P 
.03; NARES vs controls: 0.0% 0.0% vs 3.9% 2.8%; P
.001) decreased significantly in samples of nasal secretions
Table 1. Demographic and Clinical Characteristics of the 68 Study Participants
Characteristic
AR group
(n  29)
NARES group
(n  23)
Control group
(n  16)
Total
(N  68)
Sex, M/F, No. 13/16 9/14 6/10 28/40
Age, mean  SD, y 33.3  16.9 46.4  16.6 42.1  15.1 39.8  17.2
FEV1, mean  SD, % predicted 98.4  16.6 93.9  16.5 105.2  18.1 98.7  17.2
FVC, mean  SD, % 102.2  12.8 99.7  28.5 109.6  16.8 104.5  14.8
Abbreviations: AR, allergic rhinitis; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; NARES, nonallergic rhinitis with
eosinophilia syndrome.
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from patients with AR and NARES compared with controls.
No statistically significant difference was observed in total
cell counts between samples obtained from patients with AR,
patients with NARES, and controls.
Reproducibility of the Method
Total and differential cell counts of 2 samples obtained from
39 participants on 2 different occasions were compared using
the Pearson correlation coefficient (Table 3 and Fig 1). There
was a significant correlation between the 2 samples of nasal
secretions obtained on 2 different occasions for percentage of
macrophages, neutrophils, eosinophils, and epithelial cells,
indicating good reproducibility of the method. The correla-
tion between the 2 samples for total cell counts and percent-
age of lymphocytes was at the border of significance.
DISCUSSION
According to the aim of the present study, the validity of the
method based on nebulization of hypertonic solution7 for
analysis of nasal secretions obtained from 29 patients with
AR, 23 patients with NARES, and 16 controls was studied by
comparing total and differential cell counts. Analysis of nasal
secretions collected using ultrasonic nebulization of hyper-
tonic solution can distinguish patients with AR and NARES
from controls. Furthermore, the reproducibility of the method
was examined by comparing measurements in 2 samples
obtained on 2 different occasions in a group of patients with
AR, patients with NARES, and controls. The reproducibility
of this technique was found to be good for macrophages,
neutrophils, eosinophils, and epithelial cells.
In this study, nasal secretion samples were obtained by
stimulation of nasal mucosa using hypertonic saline solution
(4.5%), which is known to be a significant nasal irritant.
Commonly, isotonic saline solution has been used for stim-
ulation of nasal mucosa and collection of samples from
patients with different nasal diseases. However, recently the
use of hypertonic saline solution has increased substantially
owing to its ability to reduce edema and improve mucociliary
clearance. The improvement in mucociliary clearance is of
great importance, and it allows the collection of adequate
samples from patients and controls, who usually have a
limited amount of nasal mucosa secretion.10
The hypertonic concentration of saline solution might be
expected to affect the cellular characteristics of nasal secre-
tions. The study by Kim et al11 identified the effect of hypo-
tonic, isotonic, and hypertonic saline irrigation on secretory
mucins and morphologic features of cultured human epithe-
lial cells. According to this study, none of the saline concen-
trations significantly changed the secretion of total mucins.
Table 2. Comparison of Differential Cell Counts of Nasal Secretion Samples From Patients With Rhinitis and Controlsa
Cell count Control group AR group NARES group Total
TCC, 106/mL1 0.8  1.1 1.0  1.7 0.8  1.3 0.9  1.4
Viability, % 73.4  7.9 69.3  7.4 70.3  8.0 70.5  7.7
Macrophages, % 3.9  2.8 1.2  6.7b 0.0  0.0c 1.5  4.8
Neutrophils, % 65.4  20.7 70.8  25.9 78.0  21.0b 72.0  23.3
Eosinophils, % 0.6  0.6 20.8  23.1c 18.7  22.8c 15.3  21.5
Lymphocytes, % 0.0  0.0 1.2  1.4c 1.2  1.0c 0.9  1.2
Epithelial cells, % 30.1  19.6 5.9  12.5c 2.0  3.8c 10.4  16.9
Abbreviations: AR, allergic rhinitis; NARES, nonallergic rhinitis with eosinophilia syndrome; TCC, total cell count.
a Data are expressed as mean  SD.
b P  .05.
c P  .001.
Table 3. Reproducibility of Nasal Secretion Analysis for Total and
Differential Cell Counts
r P value
Total cell count (105) 0.32 .05
Macrophages 0.58 .001
Neutrophils 0.64 .001
Eosinophils 0.63 .001
Lymphocytes 0.31 .05
Epithelial cells 0.83 .001
Figure 1. Total cell counts (TCCs) and differential cell counts of 2
samples obtained from 39 individuals enrolled in the present study using
ultrasonic nebulization of hypertonic saline solution on 2 different occasions.
E indicates eosinophils; Ep, epithelial cells; L, lymphocytes; M, macro-
phages; N, neutrophils. Error bars represent SD. *P  .05. **P  .001.
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Treatment with hypertonic solution produced few holes in the
epithelium layer due to secretory cell exfoliation compared
with treatment with isotonic solution. However, cell-to-cell
integrity was maintained, and no damage of cells was ob-
served after irrigation with hypertonic solution.11 To our
knowledge, the effect of saline concentration on the cellular
characteristics of nasal secretions has not been reported.
However, there are indications that stimulation of lower air-
ways secretion by different saline concentrations does not
affect total and differential cell counts in selected portions of
induced sputum.12 Thus, the results of the present study might
not be affected and biased by the use of hypertonic solution
for nasal secretion collection.
Total and differential cell counts of nasal secretions ob-
tained by means of ultrasonic nebulization of hypertonic
solution can be used to monitor the activity of eosinophilic
inflammation in AR and NARES. Clinical implementation of
this method requires establishment of a reference range of
total and differential cell counts of nasal secretion samples
from controls. To our knowledge, this is the first study
attempting to define reference ranges for nasal secretions
obtained by means of ultrasonic nebulization of hypertonic
solution.7 Controls usually have a limited amount of nasal
mucosa secretion, thus making it difficult to collect a suffi-
cient amount of secretion.10 The present study analyzed only
16 samples of nasal secretions from controls. However, these
reference ranges of nasal secretions can be used as orientation
for the interpretation of data in individual patients.
Furthermore, this study demonstrates that this method7 can
discriminate between controls and patients with AR and
NARES. Samples of nasal secretion from these patients are
characterized by an increase in the percentage of eosinophils
and lymphocytes and a decrease in the percentage of epithe-
lial cells and macrophages. A previous study7 demonstrated
eosinophilia in patients with AR. This is the first study
characterizing changes in differential cell counts in samples
from patients with AR and NARES.
In the present study we examined reproducibility in 2
samples of nasal secretion obtained on 2 different occasions
using the Pearson correlation coefficient. We found that the
method is reproducible for macrophages, neutrophils, eosin-
ophils, and epithelial cells. This finding is in agreement with
the previous study.7 We also found that the reproducibility of
total cell counts and lymphocytes was at the border of sig-
nificance. This can be due to the difficulty in the accurate
recognition of this cell type or due to very low numbers of
this cell in the samples.13 In many cases, we did not count any
lymphocytes in one sample, whereas there was a low number
of lymphocytes in the other specimen, resulting in poor
reproducibility in that patient. Furthermore, the reproducibil-
ity of lymphocytes has not previously been reported.
This study shows that the analysis of samples obtained
using ultrasonic nebulization of hypertonic solution can dis-
tinguish patients with AR and NARES from controls. The
reproducibility of this technique is good for macrophages,
neutrophils, eosinophils, and epithelial cells. This method
could be used to detect nasal airway inflammation in clinical
settings.
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